Amir Heshmatpour Acquires 12,000 Shares of Neonc Technologies (NASDAQ:NTHI) Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour purchased 12,000 shares of the stock in a transaction dated Friday, August 14th. The shares were purchased at an average price of $3.79 per share, with a total value of $45,480.00. Following the transaction, the chief executive officer directly owned 3,084,000 shares of the company’s stock, valued at approximately $11,688,360. The trade was a 0.39% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Neonc Technologies Trading Up 16.4%

NASDAQ:NTHI traded up $0.69 during mid-day trading on Monday, hitting $4.91. The stock had a trading volume of 378,880 shares, compared to its average volume of 92,168. The company has a 50 day simple moving average of $4.11 and a 200-day simple moving average of $6.08. Neonc Technologies Holdings, Inc. has a 52 week low of $3.01 and a 52 week high of $12.99.

Neonc Technologies (NASDAQ:NTHI) last posted its earnings results on Friday, August 14th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.46).

Hedge Funds Weigh In On Neonc Technologies

A number of institutional investors and hedge funds have recently added to or reduced their stakes in NTHI. Barclays PLC raised its stake in shares of Neonc Technologies by 5,314.8% in the 4th quarter. Barclays PLC now owns 9,151 shares of the company’s stock worth $76,000 after buying an additional 8,982 shares in the last quarter. Goldman Sachs Group Inc. bought a new position in Neonc Technologies during the fourth quarter valued at about $124,000. OMERS ADMINISTRATION Corp acquired a new position in Neonc Technologies during the fourth quarter worth about $126,000. Royal Bank of Canada bought a new stake in Neonc Technologies in the first quarter worth about $247,000. Finally, Global Retirement Partners LLC bought a new stake in Neonc Technologies in the second quarter worth about $126,000.

Analysts Set New Price Targets

Several analysts have weighed in on the company. Maxim Group began coverage on Neonc Technologies in a research note on Monday, May 18th. They set a “buy” rating and a $20.00 target price on the stock. BTIG Research reissued a “buy” rating and set a $15.00 price target on shares of Neonc Technologies in a report on Tuesday, May 26th. Alliance Global Partners assumed coverage on shares of Neonc Technologies in a report on Tuesday, May 19th. They issued a “buy” rating and a $13.00 price objective for the company. Weiss Ratings lowered shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, June 24th. Finally, Wall Street Zen cut shares of Neonc Technologies from a “hold” rating to a “sell” rating in a research note on Saturday. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $16.00.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.